Bunkyo, Japan

Kazuya Takamochi

This inventor holds 1 USPTO granted patent. Top assignees: Juntendo Educational Foundation, Riken Corporation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuya Takamochi. Retrieved from https://idiyas.com/inventor/kazuya-takamochi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuya Takamochi: Innovator in Lung Cancer Diagnosis

Introduction

Kazuya Takamochi is a notable inventor based in Bunkyo-ku, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the differentiation of lung cancer types. His innovative approach aims to enhance the accuracy and speed of cancer diagnosis, which is crucial for effective treatment.

Latest Patents

Takamochi holds a patent for a method that differentiates between lung squamous cell carcinoma and lung adenocarcinoma. This method provides an objective and rapid assessment of lung cancer lesions with high accuracy. The patent outlines a process that involves measuring the expression level of specific DNA products in biological samples collected from lung cancer lesions. This innovative technique is designed to improve the diagnostic capabilities for healthcare professionals.

Career Highlights

Throughout his career, Kazuya Takamochi has worked with esteemed organizations such as the Juntendo Educational Foundation and RIKEN Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field of medical research and diagnostics.

Collaborations

Some of his notable coworkers include Kenji Suzuki and Tsuyoshi Saito. Their collaborative efforts have contributed to advancements in cancer research and diagnostics.

Conclusion

Kazuya Takamochi's work in developing a method for differentiating lung cancer types showcases his commitment to improving medical diagnostics. His innovative contributions are vital for enhancing patient care and treatment outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…